Search results
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 4 days agoModerna became a household name thanks to the success of its mRNA vaccine against COVID-19. Along...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 1 hour agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 1 day agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 2 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 6 hours agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Pfizer Inc. (NYSE:PFE) Shares Sold by Public Employees Retirement System of Ohio
ETF DAILY NEWS· 1 day agoPublic Employees Retirement System of Ohio reduced its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 1.8% during the 4th quarter, HoldingsChannel reports. The ...
Is It Too Late to Buy Pfizer Stock?
Motley Fool via Yahoo Finance· 1 day agoTo make matters worse, the forces behind this purported decline do not imply room for recovery. As shown on the chart, Pfizer's performance during the...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Another COVID vaccine? Yes, and here’s why
Denver Post· 4 days agovaccine has been shown to reduce the risk of having to go to the doctor with flu by 40% to 60%.” Last Wednesday, FDA’s advisers, a panel of physicians...
Here's To Science! Pfizer, Moderna Look To Combo Flu/COVID Vaccines
MediaPost· 5 days agoAlbert Bourla, Pfizer’s chief executive officer, acknowledged on Monday that, because the company’s stock price was down at the time, he gave the final sign-off on running ...
